CN103815410A - 一种调理痤疮酵素及其制备方法 - Google Patents
一种调理痤疮酵素及其制备方法 Download PDFInfo
- Publication number
- CN103815410A CN103815410A CN201410099025.1A CN201410099025A CN103815410A CN 103815410 A CN103815410 A CN 103815410A CN 201410099025 A CN201410099025 A CN 201410099025A CN 103815410 A CN103815410 A CN 103815410A
- Authority
- CN
- China
- Prior art keywords
- acne
- fermentation
- conditioning
- yeast
- ferment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 58
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 102000004190 Enzymes Human genes 0.000 title abstract description 11
- 108090000790 Enzymes Proteins 0.000 title abstract description 11
- 238000000855 fermentation Methods 0.000 claims abstract description 79
- 230000004151 fermentation Effects 0.000 claims abstract description 72
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 49
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 34
- 239000000463 material Substances 0.000 claims abstract description 21
- 239000000725 suspension Substances 0.000 claims abstract description 20
- 241001070941 Castanea Species 0.000 claims abstract description 17
- 235000014036 Castanea Nutrition 0.000 claims abstract description 17
- 241000722885 Brettanomyces Species 0.000 claims abstract description 16
- 244000168141 Geotrichum candidum Species 0.000 claims abstract description 16
- 235000017388 Geotrichum candidum Nutrition 0.000 claims abstract description 16
- 241000223253 Rhodotorula glutinis Species 0.000 claims abstract description 16
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 15
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 14
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 13
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 13
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 12
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 12
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 12
- 241000187395 Streptomyces microflavus Species 0.000 claims abstract description 12
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 12
- 210000004185 liver Anatomy 0.000 claims abstract description 11
- 238000002791 soaking Methods 0.000 claims abstract description 4
- 241000437896 Corydalis bungeana Species 0.000 claims abstract 2
- 241000628997 Flos Species 0.000 claims abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 27
- 230000003750 conditioning effect Effects 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 241000220317 Rosa Species 0.000 claims description 19
- 244000020518 Carthamus tinctorius Species 0.000 claims description 18
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 18
- 240000006688 Telosma cordata Species 0.000 claims description 16
- 235000017352 Telosma cordata Nutrition 0.000 claims description 16
- 241000767839 Semiaquilegia adoxoides Species 0.000 claims description 15
- 241000561734 Celosia cristata Species 0.000 claims description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 14
- 210000001520 comb Anatomy 0.000 claims description 14
- 241000605422 Asparagus asparagoides Species 0.000 claims description 12
- 244000057717 Streptococcus lactis Species 0.000 claims description 11
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 11
- 230000009286 beneficial effect Effects 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 11
- 241000245665 Taraxacum Species 0.000 claims description 10
- 239000011521 glass Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 230000003203 everyday effect Effects 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 241001557517 Crocanthemum scoparium Species 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 235000015203 fruit juice Nutrition 0.000 claims description 4
- 238000005286 illumination Methods 0.000 claims description 4
- 238000011081 inoculation Methods 0.000 claims description 4
- 239000002893 slag Substances 0.000 claims description 4
- 238000001228 spectrum Methods 0.000 claims description 4
- 210000000232 gallbladder Anatomy 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 2
- 240000004784 Cymbopogon citratus Species 0.000 claims 4
- 235000017897 Cymbopogon citratus Nutrition 0.000 claims 4
- 241000123865 Gynura bicolor Species 0.000 claims 1
- 241001314539 Nervilia Species 0.000 claims 1
- 244000136184 Viola japonica Species 0.000 claims 1
- 235000008611 Viola japonica Nutrition 0.000 claims 1
- 244000005706 microflora Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 210000004072 lung Anatomy 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 10
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 5
- 240000001949 Taraxacum officinale Species 0.000 abstract description 3
- 210000000936 intestine Anatomy 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 abstract 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000194036 Lactococcus Species 0.000 abstract 1
- 235000004789 Rosa xanthina Nutrition 0.000 abstract 1
- 241000109329 Rosa xanthina Species 0.000 abstract 1
- 241000767840 Semiaquilegia Species 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
- 244000022778 quail grass Species 0.000 abstract 1
- 230000003595 spectral effect Effects 0.000 abstract 1
- 238000010025 steaming Methods 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 13
- 241000700647 Variola virus Species 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 238000010564 aerobic fermentation Methods 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 239000002574 poison Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 206010033733 Papule Diseases 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 4
- 230000008602 contraction Effects 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 3
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 3
- -1 Compound Cyproterone Acetate Chemical class 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 235000016804 zinc Nutrition 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 206010002368 Anger Diseases 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 244000241235 Citrullus lanatus Species 0.000 description 2
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- 235000009811 Momordica charantia Nutrition 0.000 description 2
- 240000001910 Momordica cochinchinensis Species 0.000 description 2
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 2
- 235000018365 Momordica dioica Nutrition 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 230000002280 anti-androgenic effect Effects 0.000 description 2
- 230000001088 anti-asthma Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000000051 antiandrogen Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 229930182486 flavonoid glycoside Natural products 0.000 description 2
- 150000007955 flavonoid glycosides Chemical class 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 229960005280 isotretinoin Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 229940127234 oral contraceptive Drugs 0.000 description 2
- 239000003539 oral contraceptive agent Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- OXEDXHIBHVMDST-UHFFFAOYSA-N 12Z-octadecenoic acid Natural products CCCCCC=CCCCCCCCCCCC(O)=O OXEDXHIBHVMDST-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- DLHXRDUXNVEIEY-UHFFFAOYSA-N 7-Methylcoumarin Chemical compound C1=CC(=O)OC2=CC(C)=CC=C21 DLHXRDUXNVEIEY-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000501 Acne conglobata Diseases 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- ZROGCCBNZBKLEL-FHXNIQKESA-N Astilbin Natural products O([C@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 ZROGCCBNZBKLEL-FHXNIQKESA-N 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- DPQCZNIGGNJGTD-UHFFFAOYSA-N Chloride-(??)-2-Methylpentanoic acid Natural products CCCCCCC=CCCCCCCCCCC(=O)OC(C)C(C)OC(=O)CCCCCCCC=CCCCCCC DPQCZNIGGNJGTD-UHFFFAOYSA-N 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- DPQCZNIGGNJGTD-MVCBGFDASA-N Coixenolide Chemical compound CCCCCC\C=C\CCCCCCCCCC(=O)O[C@@H](C)[C@@H](C)OC(=O)CCCCCCC\C=C/CCCCCC DPQCZNIGGNJGTD-MVCBGFDASA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 235000016936 Dendrocalamus strictus Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- VQUPQWGKORWZII-RPJYBVRZSA-N Isoengeletin Chemical compound C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2[C@H](OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)O)O VQUPQWGKORWZII-RPJYBVRZSA-N 0.000 description 1
- GFJNBLOMWYSKSS-UHFFFAOYSA-N Isoglycyrol Natural products COc1c2CCC(C)(C)Oc2cc3OC(=O)c4c(oc5c(O)cccc45)c13 GFJNBLOMWYSKSS-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- PUPKKEQDLNREIM-UHFFFAOYSA-N Kaempferitin Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(OC3C(C(O)C(O)C(C)O3)O)=C(C=3C=CC(O)=CC=3)OC2=C1 PUPKKEQDLNREIM-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- MVAUGMLUJKTORM-UHFFFAOYSA-N Licoricidin Natural products COc1cc2OCC(Cc2cc1CC=C(C)C)c3ccc(O)c(CC=C(C)C)c3O MVAUGMLUJKTORM-UHFFFAOYSA-N 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- VQUPQWGKORWZII-UHFFFAOYSA-N Neoisoengelitin Natural products OC1C(O)C(O)C(C)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C=C1 VQUPQWGKORWZII-UHFFFAOYSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-USTPAGJBSA-N Neoisoliquiritigenin Natural products O=C(/C=C/c1ccc(O)cc1)c1c(O)cc(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc1 XQWFHGOIUZFQPJ-USTPAGJBSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-LXGDFETPSA-N Neoisoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-LXGDFETPSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-UHFFFAOYSA-N Neoisoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1O)=CC=C1C(=O)C=CC1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- DLUTTXMPJCVUFR-HJCIYZGTSA-N Parillin Chemical class C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1C[C@H]2CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(OC[C@@H](C)CC1)O5)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DLUTTXMPJCVUFR-HJCIYZGTSA-N 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010036049 Polycystic ovaries Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 235000011449 Rosa Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- GMBQZIIUCVWOCD-WWASVFFGSA-N Sarsapogenine Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 GMBQZIIUCVWOCD-WWASVFFGSA-N 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 241000362909 Smilax <beetle> Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- RTMWIZOXNKJHRE-UHFFFAOYSA-N Tigogenin Natural products CC1COC2CC(C)(OC12)C3CCC4C5CCC6CC(O)CCC6(C)C5CCC34C RTMWIZOXNKJHRE-UHFFFAOYSA-N 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003776 Vitamin B4 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- SOSLMHZOJATCCP-PADPQNGGSA-N afzelin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1)C1=C(c2ccc(O)cc2)Oc2c(c(O)cc(O)c2)C1=O SOSLMHZOJATCCP-PADPQNGGSA-N 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- ZROGCCBNZBKLEL-MPRHSVQHSA-N astilbin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1C(=O)C2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1 ZROGCCBNZBKLEL-MPRHSVQHSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- RWYFURDDADFSHT-RBBHPAOJSA-N diane Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.C1=C(Cl)C2=CC(=O)[C@@H]3CC3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RWYFURDDADFSHT-RBBHPAOJSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000037189 immune system physiology Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- CFWLRXJPRRCJTI-UHFFFAOYSA-N iso-glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CCC(C)(C)O2)C2=C1 CFWLRXJPRRCJTI-UHFFFAOYSA-N 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- ZMGSKTZDVIZXJS-UHFFFAOYSA-N kaempferitrin Natural products CC1OC(OC2C(Oc3cc(OC4OC(C)C(O)C(O)C4O)cc(O)c3C2=O)c5ccc(O)cc5)C(O)C(O)C1O ZMGSKTZDVIZXJS-UHFFFAOYSA-N 0.000 description 1
- PUPKKEQDLNREIM-QNSQPKOQSA-N kaempferol 3,7-di-O-alpha-L-rhamnoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=CC(O)=C2C(=O)C(O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=C(C=3C=CC(O)=CC=3)OC2=C1 PUPKKEQDLNREIM-QNSQPKOQSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- GBRZTUJCDFSIHM-KRWDZBQOSA-N licoricidin Chemical compound C1([C@@H]2COC=3C=C(O)C(CC=C(C)C)=C(C=3C2)OC)=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-KRWDZBQOSA-N 0.000 description 1
- GBRZTUJCDFSIHM-UHFFFAOYSA-N licorisoflavan B Natural products C1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OCC1C1=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-UHFFFAOYSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 description 1
- SUTSVCLKBLJSPQ-UHFFFAOYSA-N luteolin 7-glucoside Natural products OC1C(O)C(O)C(CO)OC1C1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 SUTSVCLKBLJSPQ-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000008264 rhamnoses Chemical class 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 210000003859 smegma Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229960000565 tazarotene Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000008979 vitamin B4 Nutrition 0.000 description 1
- 239000011579 vitamin B4 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/231—Lactis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及了一种调理痤疮酵素及其制备方法;其原料成分为:A1:薏苡仁40%、红花3%、鸡冠花5%、菊花5%、玫瑰花5%、金银花3%、蒲公英3%、地丁8%、天葵10%、枇杷叶10%、甘草5%、土茯苓3%;益生菌由:栗酒酵母2%、粘红酵母2%、白地霉2%、产膜酵母2%、酒香酵母2%、细黄链霉菌1%、植物乳酸杆菌3%,乳酸链球菌2%组成的益生菌,其制备方法如下:依据材料特性经浸泡蒸熟或粉碎的不同工艺依据不同的发酵阶段接种不同的菌群经糖化,醇化,醋化,乳酸化四级发酵,期间经过光谱控制照射,发酵84天后所得悬液即为调理痤疮酵素;本发明具有清肝润肺,健脾整肠,祛湿清热,改善因湿热体质引起的痤疮问题。
Description
技术领域
本发明涉及一种调理痤疮酵素及其制备方法,属于保健食品技术领域。
背景技术
痤疮是美容皮肤科的常见病种之一,又叫青春痘,面皰或粉刺、皮囊炎,多见于青年人的面部及胸、背、肩等部位。通常是圆锥形的小红疙瘩,有的有黑头,多由皮脂腺分泌过多,消化不良,便秘等引起。现在市面上五花八门的去痘化妆品,保养品是否对治疗痤疮(痘痘)有效?能起到多大的作用?有人在报刊网路上看到用芦荟切开涂在患处,可以治疗痘痘,一试之下还真的有效果,另外有人说用枸杞,蜂蜜捣烂涂在患处,也有治疗青春痘,方法林林总总的很多,但都是使用在表面上,有点效果但过了一阵子又长出来了,有些人晚上睡不好失眠了或因工作问题熬夜了,隔天早上都会带有口臭,严重一点的脸上就会冒出一点一点的痘痘,常常会听到他们说一句话“又上火了”。其实这句话是阐明了痘痘的真正根本。脸上长满痘痘的人一般都会有口臭,在平常的饮食,睡眠,排便,情绪等情况肯定是很不如意,一般常见的为饮食总是不香,但是爱吃肉,平常大便不成形,爱沾马桶上,情绪急躁,容易生气发怒。这些的现象都是湿热体质的表现。
知道了长痘痘的原因是由湿热而引起,但一般人只会拿清洁品、保养品,去洗、抹去涂,就算外表的现象消失了,但是身体内部没有真正的得到改善,过了一阵子痘痘又冒出来了,所以要远离痘痘的根本办法,就是祛除湿热,调理身体的体质,才能彻彻底底的解决这个烦人的“痘痘”。要想彻底的解决痘痘的问题,首先要在饮食上改变。一日三餐,定点定时,并且不要过饱,8分饱即可,但现代人的观念则是“未饥先食,未渴先饮”,这样失去了天生的饥饿感,这种的饮食习惯也是造成很多疾病的根源,也是导致脾胃功能失调,而使水湿滞留于体内,产生了水湿导致汽化,湿热体质因此而起,也使得我们的身体丧失了应有的免疫能力。尤其现代人运动量少,过度的饱食,对健康非常不利。
如何因应现代人的饮食观念,预防因湿热体质造成容易“上火”,也就是长痘痘呢?痤疮的发生在西医的角度是由于人体内性激素平衡失调引起的,也就是大家常说的内分泌失调,一般情况下是雌激素水平,孕激素水平相对过低,所以市面上用西药来治疗痤疮的常用方法有(1)局部外用药物 维A酸类(维A酸乳膏、阿达帕林凝胶、他扎罗汀凝胶)、过氧化苯甲酰、抗生素类(克林霉素、红霉素、氯霉素等)、壬二酸、硫磺洗剂等。(2)口服抗生素 首选四环素类(米诺环素、多西环素等),其次为大环内酯类(红霉素),避免选择常用于治疗系统感染的抗生素如左氧氟沙星等。抗生素疗程通常6~12周。(3)口服异维A酸 对于严重的痤疮,口服异维A酸是标准疗法,也是目前治疗痤疮最有效的方法。疗程以达到最小累积剂量60mg/kg为目标。(4)抗雄激素治疗 如口服避孕药复方醋酸环丙孕酮片(商品名达英-35),适用于女性中、重度痤疮患者,伴有雄激素水平过高表现(如多毛、皮脂溢出等)或多囊卵巢综合征。发型痤疮及月经期前痤疮显著加重的女性患者也可考虑应用口服避孕药。(5)口服糖皮质激素,主要用于暴发性或聚合性痤疮,遵循短期、小剂量、与其他方法联合应用的原则。归纳起来西药用的是抗雄激素或是抗生素来对治,是治表不治根,容易复发,也会引起很多的副作用。中医的认为痤疮是由肝火偏旺,湿热过剩所导致,针对这个病因,中医采用平泄肝火,清热利湿中药来治疗,效果比较好,而且不容易复发,也没有什么副作用,引起痤疮的因素有下面的五种,1.肺热痤疮,原因为肺有宿热。复感风邪,遂使肺热不得宣泄而引起,具体是面部出现丘疹,形如栗米,可挤出白粉色油状物,皮疹多以鼻子周围为多,也可见于前额间或有黑头粉刺,且伴有口鼻干燥,大便干结的现象。2.血热痤疮,多由情志内伤,气分郁结,日久化热,热伏营血所致,血热痤疮的症状是,颜面丘疹以口鼻及两眉间的部位较多,面部潮热明显,女性还有月经前后丘疹增多。3.胃热痤疮,胃热引起的痤疮,多是因为饮食不节,过食肥甘之物,使肠胃燥结,中焦积热,郁于面部皮肤而致,4.热毒痤疮,热毒引起的痤疮多由肺胃蕴热上炎,复感外界毒邪,热毒相结,蕴于面部皮肤引起,热毒痤疮的症状为面部有丘疹,以小脓疱为主,周围常有红晕,感觉疼痛,严重时可火欣红肿痛,5.湿毒血瘀痤疮,湿毒血瘀引起的痤疮,多由素体蕴湿,郁于肌肤,复感外界毒邪,致湿毒凝聚,阻滞经络,气血不和而成,湿毒血瘀痤疮的症状除了丘疹,脓疱外,常以结节囊肿为主,皮肤出油较多。综合上述的痤疮病理,本发明采用润肺,清热,凉血,清泻胃肠,除湿化痰的原则,配合有机种植的花卉,水果,中药材,配合微生物发酵及其衍生出的活性蛋白酶,脂肪酶和超氧化物歧化酶,提供给容易上火长痤疮的人群使用。
发明内容
本发明是提供一种以薏苡仁、红花、鸡冠花、菊花、玫瑰花、金银花、蒲公英、地丁、天葵、枇杷叶、土茯苓、甘草经由益生菌群发酵后制取出调理肝胆湿热体质酵素;
(1)、材料配比:薏苡仁40%、红花3%、鸡冠花5%、菊花5%、玫瑰花5%、金银花3%、蒲公英3%、地丁8%、天葵10%、枇杷叶10%、甘草5%、土茯苓3%;
(2)、益生菌群:栗酒酵母2%、粘红酵母2%、白地霉2%、产膜酵母2%、酒香酵母2%、细黄链霉菌1%、植物乳酸杆菌3%乳酸链球菌2%组成的益生菌;
(3)发酵制备流程:
(3-1)、将薏苡仁用75℃水浸泡2H后各自用蒸锅蒸烂,然后用25℃水水浴法,待材料冷却后,盖上纱布保湿备用。
(3-2)、将3-1)步骤完成后的放入发酵釜中,投入栗酒酵母1%、粘红酵母1%、白地霉1%、,进行糖化与醇化发酵,发酵时间7天,温度维持在25-32℃之间,PH值4.6-5.8之间,期间需保持氧气的通氧量;
(3-3)、将3-2)步骤发酵完成后,在原发酵釜中再投入产膜酵母1%、酒香酵母1%进行二次发酵,发酵期间7天,温度维持在35-36℃,PH值维持在5.8-6.8之间,如PH值不在范围之内,用小苏或醋酸打进行调整。
(3-4)、将红花、鸡冠花、菊花、玫瑰花、金银花、蒲公英、地丁、天葵、枇杷叶、土茯苓用果汁机打成泥状后放入发酵釜中,加入蒸馏水,水的高度以淹没材料10cm为原则,接种栗酒酵母1%、粘红酵母1%、白地霉1%、发酵天数7天,期间保持发酵釜的温度在28℃,PH值维持在4.6-5.8之间,期间每天3-10点,16-21点,照射光谱470um,亮度1500流明的灯光;
(3-5)、将3-4)步骤发酵完成后,在原发酵釜中再投入产膜酵母1%、酒香酵母1%、细黄链霉菌1%进行二次发酵,发酵期间7天,温度维持在35-36℃,PH值维持在5.8-6.8之间,如PH值不在范围之内,用小苏或醋酸打进行调整;
(3-6)、取3-3)与3-4)步骤发酵完成后的悬液与材料渣,以1:1:1的比例混合,投入甘草后进一步的接种植物乳酸杆菌3%,乳酸链球菌2%,发酵期间60天,期间维持发酵温度35-37℃,期间每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(3-7)、用3000目滤网过滤3-6)步骤发酵后的残渣取悬液。
(3-8)、进一步的将3-7)步骤完成后的悬液装入棕色玻璃瓶后, 用121℃蒸汽灭菌,所制取的悬液即为调理痤疮酵素;
本发明的材料详细如下
薏苡仁:含有薏苡仁酯;并含脂肪油,油中含肉豆蔻酸、芸苔甾醇、棕榈酸、十八烯酸、豆甾醇等,尚含氨基酸、蛋白质、糖类,有健脾渗湿,除痹止泻,用于水肿、脚气、小便不利、湿痹拘挛、脾虚泄泻的功效;
红花:含红色的和黄色的色素,从中分离得到:红花甙,前红花甙,红花黄色素,红花明甙。又含多酚类成分:绿原酸,加啡酸,儿茶酚,焦性儿茶酚,多巴,还含15α,20β-二羟基-Δ4-娠烯-3-酮,另尚含脂肪油称红花油,是棕榈酸、硬脂酸、花生酸、油酸、亚油酸、亚麻酸等的甘油酯类。叶含木犀草素-7-葡萄糖苷,尚含木聚糖类,苦味甾体苷等。用于血瘀诸证,温病热入营血引起的发斑、发疹。西红花能凉血解毒;
鸡冠花:其味甘、涩、凉、归肝、大肠经,含有蛋白质、脂肪、叶酸、泛酸、维生素B1、B2、B4、B12、C、D、E、K等多种维生素,以及山柰甙、苋菜红甙、蒎立醇、松醇、硝酸钾、21种氨基酸、13种微量元素和51种以上的天然和酶辅酶,其中种子中蛋白质含量高达73%,可以补充粮食含量之不足。其种子有凉血止血之功用,主治肠风便血、赤血、痢疾、崩漏、带下、淋浊等症。而鸡冠花其苗也有一定的药用,可主治痔疮、痢疾、吐血、衄血、血崩、荨麻疹等病症。食用其花瓣和花籽,能为人体提供营养平衡物;
菊花:具有疏风、清热、明目、解毒之功效。主要治疗头痛、眩晕、目赤、心胸烦热、疔疮、肿毒等症。现代药理研究表明,菊花具有治疗冠心病、降低血压、预防高血脂、抗菌、抗病毒、抗炎、抗衰老等多种药理活性;
玫瑰花:《本草正文》中道:“玫瑰花,清而不浊,和而不猛,柔肝醒胃,疏气活血,宣通窒滞而绝无辛温刚燥之弊,断推气分药之中,最有捷效而最驯良,芳香诸品,殆无其匹”,玫瑰花中含有300多种化学成份,如芳香的醇、醛、脂肪酸、酚和含香精的油和脂,常食玫瑰制品中以柔肝醒胃,舒气活血,美容养颜,令人神爽。玫瑰初开的花朵及根可入药,有理气、活血、收敛等作用、主治月经不调,跌打损伤、肝气胃痛,乳臃肿痛等症。玫瑰果的果肉,可制成果酱,具有特殊风味,果实含有丰富的维生素C及维生素P,可预防急、慢性传染病、冠心病、肝病和阻止产生致癌物质等。用玫瑰花瓣以蒸馏法提炼而得的玫瑰精油(称玫瑰露),可活化男性荷尔蒙及精子。玫瑰露还可以改善皮肤质地,促进血液循环及新陈代谢;
金银花:自古以来就以它的药用价值广泛而著名。其功效主要是清热解毒,主治温病发热、热毒血痢、痈疽疔毒等。现代研究证明,金银花含有绿原酸、木犀草素苷等药理活性成分,对溶血性链球菌、金黄葡萄球菌等多种致病菌及上呼吸道感染致病毒等有较强的抑制力,另外还可增强免疫力、抗早孕、护肝、抗肿瘤、消炎、解热、止血(凝血)、抑制肠道吸收胆固醇等,其临床用途非常广泛;
蒲公英:植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分,有利尿、缓泻、退黄疸、利胆等功效。蒲公英同时含有蛋白质、脂肪、碳水化合物、微量元素及维生素等,有丰富的营养价值。其中含有的胡萝卜素和C及矿物质,对消化不良、便秘都有改善的作用。另外叶子还有改善湿疹、舒缓皮肤炎的功效,根则具有消炎作用,花朵煎成药汁可以去除雀斑;
地丁:地丁所含黄酮甙类及有机酸对金色葡萄球菌、猪巴氏杆菌、大肠杆菌、链球菌和沙门氏菌都有较强的抑菌作用。所富集微量元素,对人体内多种酶的活性有作用,对核酸蛋白的合成、免疫过程、细胞繁殖都有直接或间接的作用,可促进上皮细胞修复,使细胞分裂增加,T细胞增高,活性增加,从而对生物体的免疫功能起调节作用,通过酶系统发挥对机体代谢的调节和控制;所含锌可抗病毒,并能刺激抗毒素的合成,提高对传染病的抵抗力,是其:“清热解毒”、“治疽疗毒”的基础;
天葵:天葵味甘,微酸,性凉。具清热解毒、润肺止咳、散瘀消肿、生津止渴之功效,治外感高热、中暑发烧,肺热咳嗽,伤风声嘶,痈肿疮毒,跌打肿痛等症提高机体免疫力和治疗某些疾病。大量的研究资料表明,锌、锰、维生素E、黄酮类物质等成分具有增强机体免疫力的作用。铁、铜等对治疗一些血液病(如营养型贫血)有很好的疗效。生理活性物质有清除自由基和抵抗衰老的作用。每100g叶片中含水分92.79g、粗脂肪0.18g、粗蛋白2.11g、粗纤维0.94g、维生素A5644国际单位、维生素B10.01mg、维生素B20.13mg、维生素C0.78mg、钾136.41mg、钙89.66mg、铁1.61mg、磷18.73mg、烟酸0.59mg。鲜嫩茎叶和嫩梢的维生素C含量较高,还含有黄酮苷等。据测定,每100g干物质中含钙1.4~3.0g、磷0.17~0.39g、铜1.34~2.52mg、铁20.97mg、锌2.60~7.22mg、锰0.47~14.87mg;
枇杷叶:其性苦,寒,归胃经,肺经,具镇咳、祛痰、平喘作用,所含苦杏仁甙在体内水解产生的氢氰酸有止咳作用。水煎剂或乙酸乙酯提取物有祛痰和平喘作用,其叶所含之挥发油有轻度祛痰作用,亦有报告指出,枇杷叶止咳作用强, 祛痰作用较差,具抗菌作用,实验表明: 枇杷叶提取物对白色或金黄色葡萄球菌、肺炎双球菌、福氏痢疾杆菌均有抗菌作用;
土茯苓:性味:甘淡,平。归经:肝经,胃经,脾经。其功能功能:解毒,除湿,利关节。主治:治梅毒,淋浊,筋骨挛痛,脚气,疗疔疮,痈肿,瘰疬,梅毒及汞中毒所致的肢体拘挛,筋骨疼痛。起根茎含皂苷、鞣质、树脂等。其根含生物碱、挥发油、己糖、鞣质、植物甾醇及亚油酸、油酸等。根茎含菝葜皂苷类,其中一种已知为薯蓣皂苷元与1分子葡萄糖、2分子鼠李糖组成;皂苷元尚有提果皂苷元。另含落新妇苷、异黄杞苷、琥珀酸、胡萝卜苷、棕榈酸、β-谷甾醇,以及生物碱、挥发油、糖、鞣质、树脂、甾醇、淀粉等;
甘草:甘草含有多种化学成分,主要成分有甘草酸、甘草甙等。甘草的化学组成极为复杂,目前
为止从甘草中分离出的化合物有甘草甜素、甘草次酸、甘草甙、异甘草甙、新甘草甙、新异甘草甙、甘草素、异甘草素以及甘草西定、甘草醇、异甘草醇、7-甲基香豆精、伞形花内酯等数十种化合物,大量的研究表明,甘草甜素和黄酮类物质是甘草中最重要的生理活性物质。具有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
本发明的优点:
本发明提供的发酵方法,是应用有机种植的根,茎,叶,花,果的各种性征,配合中医的归经性质与药膳同源的理论合理配伍,严格控制禁止使用化肥,农药与转基因的作物,本着调理痤疮的利湿清热的原则,配合益生菌群里的各种菌种的发酵特性与同化特性,应用材料本身具有的微量元素提供给微生物生长所需的元素,并在每一发酵阶段期间,创造各种微生物不同的生长环境特性,配合大自然在早晨太阳初升起时的阴阳两气的气场进行搅拌,以吸收大自然的气场精华,提供适合微生物工作时配合特定的光波与音波增强微生物的功能,上述的原材料经过醇化、醋化、乳酸化的发酵阶段,发酵出具有活性调理肝胆湿热体质酵素,采用的材料含有丰富的活性酶,维生素,矿物质和微生物的次生产物,酶中含有蛋白酶,脂肪酶和超氧化物歧化酶是本益生菌群的主要功效酶,提供给痤疮的人用于清肝,润肺,健脾,整肠胃,祛湿清热,改善因湿热体质引起的痤疮问题。
附图说明
图1、一种调痤疮酵素及其制备方法:
A1:浸泡 A2:蒸熟 A3:水浴 A4:好氧发酵 A5:厌氧发酵
B1:材料粉碎 B2:好氧发酵 B3:厌氧发酵
C1:乳酸化发酵 C2:过滤 C3:装罐灭菌。
具体实施方式
下面结合具体附图和实施例对本发明的一种调理痤疮体质酵素及其制备方法做进一步说明,
实施例1
材料配比:薏苡仁40%、红花3%、鸡冠花5%、菊花5%、玫瑰花5%、金银花3%、蒲公英3%、地丁8%、天葵10%、枇杷叶10%、甘草5%、土茯苓3%;
益生菌群:栗酒酵母2%、粘红酵母2%、白地霉2%、产膜酵母2%、酒香酵母2%、细黄链霉菌、1%、植物乳酸杆菌3%,乳酸链球菌2%组成的益生菌。
本发明的发酵工艺流程:
(A1)、将薏苡仁用75℃水浸泡2H;
(A2)、进一步的将A1)完成的材料用蒸锅蒸烂;
(A3)、进一步的将A2)步骤完成后的材料用25℃水水浴,待材料冷却后,盖上纱布保湿备用;
(A4)、将A3)步骤完成后的放入发酵釜中,投入栗酒酵母1%、粘红酵母1%、白地霉1%、,进行糖化与醇化发酵,发酵时间7天,温度维持在25-32℃之间,PH值4.6-5.8之间,期间需保持氧气的通气量,进行好氧发酵;
(A5)、将A4)步骤发酵完成后,在原发酵釜中再投入产膜酵母1%、酒香酵母1%进行二次发酵,发酵期间7天,温度维持在35-36℃,PH值维持在5.8-6.8之间,如PH值不在范围之内,用小苏打或醋酸进行调整,发酵期间必须维持发酵釜是厌氧的条件;
(B1)、将红花、鸡冠花、菊花、玫瑰花、金银花、蒲公英、地丁、天葵、枇杷叶、土茯苓用果汁机打成泥状后放入发酵釜中,加入蒸馏水,水的高度以淹没材料10cm为原则,接种栗酒酵母1%、粘红酵母1%、白地霉1%,发酵天数7天,期间保持发酵釜的温度在28℃,PH值维持在4.6-5.8之间,期间每天3-10点,16-21点,照射光谱470um,亮度1500流明的灯光,期间需要维持发酵釜的通气,进行好氧发酵;
(B2)、将B1)步骤发酵完成后,在原发酵釜中再投入产膜酵母1%、酒香酵母1%、细黄链霉菌1%进行二次发酵,发酵期间7天,温度维持在35-36℃,PH值维持在5.8-6.8之间,如PH值不在范围之内,用小苏打或醋酸进行调整,必须维持发酵釜是厌氧的条件;
(C1)、取A1)与A2)步骤发酵完成后的悬液与材料渣,以1:1的比例混合,投入甘草后进一步的接种植物乳酸杆菌3%,乳酸链球菌2%,发酵期间60天,期间维持发酵温度35-37℃,期间每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(C2)、用3000目滤网过滤C1)步骤发酵后的残渣取悬液;
(C3)、进一步的将C2)步骤完成后的悬液装入棕色玻璃瓶后,用121℃蒸汽灭菌,所制取的悬液即为调理痤疮酵素;
下列实例说明不涉及本专利的保护范围
实施例2
材料配比:粳米40%、红花3%、鸡冠花5%、菊花5%、玫瑰花5%、西瓜10%、苦瓜10%、黄瓜10%,地丁3%、天葵3%、甘草3%、土茯苓3%;
益生菌群:益生菌群:栗酒酵母2%、粘红酵母2%、白地霉2%、产膜酵母2%、酒香酵母2%、细黄链霉菌、1%、植物乳酸杆菌3%,乳酸链球菌2%组成的益生菌;
(A1)、将粳米用清水浸泡18H后用粉碎机粉碎成300目粉状;
(A2)、将A1)步骤完成后的放入发酵釜中,投入栗酒酵母1%、粘红酵母1%、白地霉1%、,进行糖化与醇化发酵,发酵时间7天,温度维持在25-32℃之间,PH值4.6-5.8之间,期间需保持氧气的通气量,进行好氧发酵;
(A3)将A2)步骤发酵完成后,在原发酵釜中再投入产膜酵母1%、酒香酵母1%进行二次发酵,发酵期间7天,温度维持在35-36℃,PH值维持在5.8-6.8之间,如PH值不在范围之内,用小苏打或醋酸进行调整,发酵期间必须维持发酵釜是厌氧的条件;
(B1)、红花、鸡冠花、菊花、玫瑰花、西瓜、苦瓜、黄瓜、地丁、天葵、甘草、土茯苓用果汁机打成泥状后放入发酵釜中,加入蒸馏水,水的高度以淹没材料10cm为原则;
(B2)、进一步的接种栗酒酵母1%、粘红酵母1%、白地霉1%,发酵天数7天,期间保持发酵釜的温度在28℃,PH值维持在4.6-5.8之间,期间每天3-10点,16-21点,照射光谱470um,亮度1500流明的灯光,期间需要维持发酵釜的通气,进行好氧发酵;
(B3)、将B2)步骤发酵完成后,在原发酵釜中,进一步接种产膜酵母1%、酒香酵母1%、细黄链霉菌1%进行二次发酵,发酵期间7天,温度维持在35-36℃,PH值维持在5.8-6.8之间,如PH值不在范围之内,用小苏打或醋酸进行调整,必须维持发酵釜是厌氧的条件;
(C1)、取A1)与A2)步骤发酵完成后的悬液与材料渣,以1:1的比例混合,投入甘草后进一步的接种植物乳酸杆菌3%,乳酸链球菌2%,发酵期间60天,期间维持发酵温度35-37℃,期间每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(C2)、用3000目滤网过滤C1)步骤发酵后的残渣取悬液;
(C3)、进一步的将C2)步骤完成后的悬液装入棕色玻璃瓶后,用121℃蒸汽灭菌,所制取的悬液即为调理痤疮酵素;
实施例3
材料配比:薏苡仁40%、红花3%、鸡冠花5%、菊花5%、玫瑰花5%、金银花3%、蒲公英3%、地丁8%、天葵10%、枇杷叶10%、土茯苓3%、甘草5%;
益生菌群:益生菌群:栗酒酵母2%、粘红酵母2%、白地霉2%、产膜酵母2%、酒香酵母2%、细黄链霉菌1%、植物乳酸杆菌3%,乳酸链球菌2%组成的益生菌;
(A1)、将糙薏苡仁用清水浸泡18H后用粉碎机粉碎;
(A2)、将红花、鸡冠花、菊花、玫瑰花、金银花、蒲公英、地丁、天葵、枇杷叶、土茯苓,用粉碎机粉碎。
(A3)、将A1)A2)步骤完成后的材料混合放入发酵釜中,投入栗酒酵母1%、粘红酵母1%、白地霉1%、,进行糖化与醇化发酵,发酵时间7天,温度维持在25-32℃之间,PH值4.6-5.8之间,期间需保持氧气的通气量,进行好氧发酵;
(A4)、将A3)步骤发酵完成后,在原发酵釜中再投入产膜酵母1%、酒香酵母1%、细黄链霉菌1%进行二次发酵,发酵期间21天,温度维持在35-36℃,PH值维持在5.8-6.8之间,如PH值不在范围之内,用小苏打或醋酸进行调整,发酵期间必须维持发酵釜是厌氧的条件;
(A5) 、进一步的将A2)步骤发酵完成后,投入甘草后再进一步的接种植物乳酸杆菌3%,乳酸链球菌2%,发酵期间60天,期间维持发酵温度35-37℃,期间每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(A6)、用3000目滤网过滤C1)步骤发酵后的残渣取悬液;
(A7)、进一步的将A6)步骤完成后的悬液装入棕色玻璃瓶后,用121℃蒸汽灭菌,所制取的悬液即为调理痤疮酵素。
本发明的调理痤疮酵素具有清火解热,舒肝理气、健脾利湿,利肠胃,益肾补元的功能;解决因为湿热体质引起的痤疮、腹胀,大便不调等症状,食用方法:用调理痤疮酵素与30-35℃的温开水以1:10的比例稀释后于早中晚各饮用一次,每次250ml;本发明的功效是用微生物发酵的功能,制取出材料中的各种适合脾,肝,肾,肺的活性营养元素,可以帮助清火解热、舒肝理气、健脾利湿,增强人体免疫力预防体内湿热而引起的痤疮,本品适合大部分青年人使用,禁用人群:妊娠中妇女。
虽然本发明已以较佳实施例揭示如上,然其并非用以限定本发明,任何本领域技术人员,在不脱离本发明的精神和范围内,当可作些许的修改和完善,因此本发明的保护范围当以权利要求书所界定的为准。
Claims (7)
1.一种调理痤疮酵素及其制备方法,其特征是:以薏苡仁、红花、鸡冠花、菊花、玫瑰花、金银花、蒲公英、地丁、天葵、枇杷叶、土茯苓、甘草经由益生菌群发酵后制取出调理肝胆湿热体质酵素。
2.一种调理痤疮酵素及其制备方法,其特征是:采用以下工艺步骤:
(A1)、材料配比:薏苡仁40%、红花3%、鸡冠花5%、菊花5%、玫瑰花5%、金银花3%、蒲公英3%、地丁8%、天葵10%、枇杷叶10%、甘草5%、土茯苓3%;
(A2)、益生菌群:栗酒酵母2%、粘红酵母2%、白地霉2%、产膜酵母2%、酒香酵母2%、细黄链霉菌1%、植物乳酸杆菌3%,乳酸链球菌2%组成的益生菌;
(A3)、将薏苡仁用75℃水浸泡2H后各自用蒸锅蒸烂,然后用25℃水水浴法,待材料冷却后,盖上纱布保湿备用;
(A4) 将A3)步骤完成后的放入发酵釜中,投入栗酒酵母1%、粘红酵母1%、白地霉1%、,进行糖化与醇化发酵,发酵时间7天,温度维持在25-32℃之间,PH值4.6-5.8之间,期间需保持氧气的通氧量;
(A5)、将A4)步骤发酵完成后,在原发酵釜中再投入产膜酵母1%、酒香酵母1%进行二次发酵,发酵期间7天,温度维持在35-36℃,PH值维持在5.8-6.8之间,如PH值不在范围之内,用小苏打或醋酸进行调整;
(B1)、将红花、鸡冠花、菊花、玫瑰花、金银花、蒲公英、地丁、天葵、枇杷叶、土茯苓用果汁机打成泥状后放入发酵釜中,加入蒸馏水,水的高度以淹没材料10cm为原则,接种栗酒酵母1%、粘红酵母1%、白地霉1%,发酵天数7天,期间保持发酵釜的温度在28℃,PH值维持在4.6-5.8之间,期间每天3-10点,16-21点,照射光谱470um,亮度1500流明的灯光;
(B2)、将B1)步骤发酵完成后,在原发酵釜中再投入产膜酵母1%、酒香酵母1%、细黄链霉菌1%进行二次发酵,发酵期间7天,温度维持在35-36℃,PH值维持在5.8-6.8之间,如PH值不在范围之内,用小苏打或醋酸进行调整;
(C1)、取A5)与B2)步骤发酵完成后的悬液与材料渣,以1:1:1的比例混合,投入甘草后进一步的接种植物乳酸杆菌3%,乳酸链球菌2%,发酵期间60天,期间维持发酵温度35-37℃,期间每日太阳升起地平线时,依逆时钟方向搅拌7次,太阳落地平线时依顺时钟方向搅拌7次;
(C2)、用3000目滤网过滤C1)步骤发酵后的残渣取悬液;
(C3)、进一步的将C2)步骤完成后的悬液装入棕色玻璃瓶后,用121℃蒸汽灭菌,所制取的悬液即为调理痤疮酵素。
3.如权利要求2所述的一种调理痤疮酵素及其制备方法,其特征是:所述的发酵菌群由栗酒酵母、粘红酵母、白地霉、产膜酵母、酒香酵母、细黄链霉菌、植物乳酸杆菌,乳酸链球菌组成的益生菌。
4.如权利要求2所述的一种调理痤疮酵素及其制备方法,其特征是:所述的红花为藏红花,浙红花,怀红花一种或多种。
5.如权利要求2所述的一种调理痤疮酵素及其制备方法,其特征是:所述的香茅为柠檬香茅蜿蜒香茅、马丁香茅的一种或多种。
6.如权利要求2所述的一种调理痤疮酵素及其制备方法,其特征是:所述的地丁为紫花地丁、犁头草、地丁紫堇的一种或多种。
7.如权利要求2所述的一种调理痤疮酵素及其制备方法,其特征是:所述的天葵为紫背天葵、青天葵的一种或多种。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410099025.1A CN103815410A (zh) | 2014-03-18 | 2014-03-18 | 一种调理痤疮酵素及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410099025.1A CN103815410A (zh) | 2014-03-18 | 2014-03-18 | 一种调理痤疮酵素及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103815410A true CN103815410A (zh) | 2014-05-28 |
Family
ID=50750939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410099025.1A Pending CN103815410A (zh) | 2014-03-18 | 2014-03-18 | 一种调理痤疮酵素及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103815410A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105231164A (zh) * | 2015-09-24 | 2016-01-13 | 上海韬鸿化工科技有限公司 | 玫瑰酵素及其制备方法 |
CN106376921A (zh) * | 2016-08-29 | 2017-02-08 | 彭展忠 | 止咳酵素及其制作方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1154253A (zh) * | 1996-01-09 | 1997-07-16 | 曾淑纯 | 粉刺净口服液 |
CN1714835A (zh) * | 2004-06-30 | 2006-01-04 | 谷丽 | 一种治疗青春痘、脓疮的中草药 |
CN1895592A (zh) * | 2006-06-16 | 2007-01-17 | 北京华神制药有限公司 | 一种治疗面部痤疮的中药复方制剂及其制备方法 |
KR20110118998A (ko) * | 2010-04-26 | 2011-11-02 | (주)남부식품 | 한약재와 과일의 발효효소를 이용한 김치 제조방법 및 그 방법으로 제조한 김치 |
CN103027294A (zh) * | 2012-05-25 | 2013-04-10 | 深圳市中科海外科技有限公司 | 一种抗癌酵素及其制备方法 |
CN103251853A (zh) * | 2013-05-31 | 2013-08-21 | 孙彰 | 一种治疗青春痘的中药组合物 |
-
2014
- 2014-03-18 CN CN201410099025.1A patent/CN103815410A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1154253A (zh) * | 1996-01-09 | 1997-07-16 | 曾淑纯 | 粉刺净口服液 |
CN1714835A (zh) * | 2004-06-30 | 2006-01-04 | 谷丽 | 一种治疗青春痘、脓疮的中草药 |
CN1895592A (zh) * | 2006-06-16 | 2007-01-17 | 北京华神制药有限公司 | 一种治疗面部痤疮的中药复方制剂及其制备方法 |
KR20110118998A (ko) * | 2010-04-26 | 2011-11-02 | (주)남부식품 | 한약재와 과일의 발효효소를 이용한 김치 제조방법 및 그 방법으로 제조한 김치 |
CN103027294A (zh) * | 2012-05-25 | 2013-04-10 | 深圳市中科海外科技有限公司 | 一种抗癌酵素及其制备方法 |
CN103251853A (zh) * | 2013-05-31 | 2013-08-21 | 孙彰 | 一种治疗青春痘的中药组合物 |
Non-Patent Citations (1)
Title |
---|
肖森茂,等: "《百家配伍用药经验采菁》", 30 September 1992, 中国中医药出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105231164A (zh) * | 2015-09-24 | 2016-01-13 | 上海韬鸿化工科技有限公司 | 玫瑰酵素及其制备方法 |
CN106376921A (zh) * | 2016-08-29 | 2017-02-08 | 彭展忠 | 止咳酵素及其制作方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN102940155B (zh) | 一种樱桃谷鸭的雏鸭饲料及其制备方法 | |
CN102451363A (zh) | 中草药减肥茶 | |
CN106399030A (zh) | 一种保健荔枝甜酒及其制备方法 | |
CN105661090A (zh) | 一种高蛋白鸡饲料配方及其制备方法 | |
CN102511867A (zh) | 红枣阿胶浓浆 | |
CN106581360A (zh) | 改善母猪乳汁质量的益生菌发酵中药复方制剂及其制备方法 | |
CN101167992A (zh) | 一种平衡减肥和全面防治感冒和糖尿病及美容的凉爽保健啤酒 | |
CN104783003A (zh) | 用于小猪的中草药全价饲料及其制备方法 | |
KR20210001439A (ko) | 누룩발효공법을 이용한 건강식품 조성물과 그 제조방법 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN102940219B (zh) | 一种土豆饼及其制作方法 | |
CN102511866A (zh) | 红枣阿胶浓浆及其生产工艺 | |
KR20160119999A (ko) | 동의보감 원문에 근거한 국산 유기농 공진단 및 이의 제조방법 | |
CN103238757B (zh) | 一种含发酵棉粕的蛋鸡配合饲料及其制备方法 | |
CN105661031A (zh) | 一种高蛋白鸡饲料配方及其制备方法 | |
CN105249440A (zh) | 一种阿胶糕 | |
CN104873826A (zh) | 一种可清肺祛湿的茶饮及其制备方法 | |
CN102370018A (zh) | 牛蒡百合茶 | |
CN103829248A (zh) | 一种调理肝胆湿热体质酵素及其制备方法 | |
CN103815410A (zh) | 一种调理痤疮酵素及其制备方法 | |
CN102511876A (zh) | 山楂红枣浓浆 | |
CN105918658A (zh) | 一种治疗腹泻的羊饲料 | |
CN104397717A (zh) | 玉米抗便秘减肥健康食品及其生产方法 | |
CN104435356A (zh) | 抗鸡热应激的中草药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140528 |